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Abstract
Background: The aim of the present study was to investigate biofilm formation among Methicillin-resistant Staphylococcus aureus
(MRSA) isolated from children referring to a pediatric hospital in Tehran.
Methods: In total, 98 MRSA isolates were collected from children referring to a pediatric hospital during 2014 - 2015. All the isolates
were confirmed to be MRSA using PCR amplification of the mecA gene. The antibiotic susceptibility patterns of the isolates were
determined using the Kirby-Bauer disk-diffusion and E-test methods. In order to assess the ability of biofilm formation among the
isolates, Congo red agar (CRA) and Microtiter Plate (Mtp) methods were used.
Results: All the isolates were found to be susceptible to linezolid and vancomycin and, likewise, the majority was susceptible to
minocycline and rifampicin. CRA and Mtp methods showed that 81.6% and 63.3% of the MRSA isolates, respectively, were biofilm
producers.
Conclusions: The early identification of S. aureus and detection of biofilm formation by the Mtp method are essential steps towards
the prevention of the most serious nosocomial infections.
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1. Background
Staphylococcus aureus represents one of the most seri-
ous Gram-positive bacterial infections in nosocomial and
community settings (1). The pathogenicity of S. aureus
is caused by the expression of virulence factors, which
can lead to superficial skin lesions or more-serious infec-
tions such as endocarditis, bacteremia, pneumonia, and
osteomyelitis (2, 3). The development of high levels of
penicillin resistance followed by the spread of strains re-
sistant to the semi synthetic derivative of penicillin (e.g.
methicillin) and other antibiotics has made the therapy
of Staphylococcal infections an international challenge (4).
Finding Methicillin resistant Staphylococcus aureus (MRSA)
strains just two years after the clinical use of penicillinase-
resistant Penicillin put specialists into difficulty with treat-
ing these infections (5). Vancomycin is considered the
treatment of choice for MRSA cases, but recently there are
reports on the emergence of vancomycin resistance in S.
aureus isolates (6). The biofilm formation on host surfaces
is considered an important virulence factor in S. aureus iso-
lates (7, 8). Biofilm-forming Staphylococcus aureus strains
are extremely difficult to eradicate because biofilm im-
pairs antibiotic penetration and prevents normal immune
responses (9, 10).
There are many methods to identify biofilm formation
such as tube test, Congo Red Agar (CRA), Microtiter Plate
test (Mtp), bioluminescent assay, and light or fluorescence
microscopic examination (11, 12). These methods are often
subject to severe analytical limitation and unable to detect
bacterial adherence accurately (13, 14). However, the Mtp
and CRA methods have been used to investigate biofilm
formation more frequent than other methods (15-17).
In the present study, attempts were made to determine
the prevalence of antimicrobial resistance and biofilm for-
mation among MRSA isolated from children referring to a
pediatric hospital in Tehran using Mtp and CRA methods.
2. Methods
2.1. Staphylococcus aureus Isolates
In total, 98 MRSA isolates were collected from 98 chil-
dren referring to a pediatric hospital in Tehran during 2014
Copyright © 2017, Archives of Pediatric Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial
4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the
original work is properly cited
Samadi R et al.
- 2015. All strains were examined by techniques appropri-
ate for diagnosis of Staphylococcus spp. such as micro-
scopic morphology examination, catalase test, coagulase
test, mannitol fermentation on Mannitol Salt Agar and de-
oxyribonuclease (DNase) test (Merck, Germany) (18). All
the isolates were confirmed to be S. aureus and MRSA by us-
ing PCR amplification of nuc and mecA genes, respectively
(19, 20).
2.2. Antibiotic Susceptibility Test
Antimicrobial Susceptibility Test (AST) was performed
according to the guidelines of clinical and laboratory stan-
dards institute (CLSI) (2013) (21). The used antibiotic disks
in AST included penicillin (10 IU), cefoxitin (30 µg), clin-
damycin (2 µg), Linezolid (30 µg), minocycline (30 µg),
trimethoprim-sulfamethoxazole (25 µg), gentamicin (10
µg), erythromycin (15 µg), and rifampicin (5 µg), all pur-
chased from Rosco, Denmark. Vancomycin susceptibility
test was performed by E-test (Liofilchem, Italy) and the
results were interpreted according to the CLSI guidelines
(2013). S. aureus ATCC 25923 was used as quality control.
2.3. Bacterial DNA Extraction
Genomic DNA was extracted from pure cultures using
High Pure PCR Template Preparation Kit (Roche, Germany),
according to the manufacturer’s guidelines.
2.4. Detection of nuc and mecA Genes
In the present study, all MRSA isolates were screened
for the nuc and mecA genes using PCR and primers de-
scribed in Table 1. A 25µL PCR reaction mixture consisted of
12.5µL of Master Mix (SinaClon, Iran), 2µL of the DNA tem-
plate, 1 µL of each primer (20 pmol), and 8.5 µL of ddH2O.
DNA amplification was performed in a Thermocycler (Ep-
pendorf, Hamburg, Germany) with an initial denaturation
step at 95°C for 5 minutes, 30 amplification cycles each
with 45 seconds at 95°C, 45 seconds at 54°C and 55°C for
nuc and mecA genes, respectively, and 45 seconds at 72°C,
followed by an additional extension step of 5 minutes at
72°C. The amplified products were electrophoresed on 1.5%
agarose gel.
The gel was stained with Ethidium bromide (0.5 g/mL),
visualized using UV transilluminator. The PCR products of
nuc and mecA genes were sequenced and documented in
Gen Bank, NCBI.
2.5. Detection of Biofilm Formation
2.5.1. Microtiter Plate Assay (Mtp)
The 98 clinical isolates of MRSA were screened for their
ability to form biofilm using Mtp method according to
Christensen et al. (1985) with some modifications (22).
Briefly, bacterial isolates were grown in brain heart infu-
sion (BHI) with 1% glucose (Merck, Germany) and incu-
bated at 37°C overnight (13). Cultures were diluted 1:20 in
fresh BHI-0.1% glucose. Then, 200 µL of the diluted solu-
tion was added to wells of a flat-bottomed polystyrene mi-
crotitre plate and incubated for 48 hours at 37°C. The neg-
ative control wells contained 200 µL of BHI-0.1% glucose.
The wells were gently washed 3 times with phosphate-
buffered saline (PBS; pH 7.2), fixed with sodium acetate
(2%) for 10 minutes, dried at room temperature, and then
strained with 0.1% crystal violet. After removing the crystal
violet solution, the wells were washed with PBS to remove
unbound dye. The optical densities (ODs) of the plates
were observed at 630 nm using a Microtiter plate reader.
Each assay was performed in duplicate. As a negative con-
trol, brain heart infusion broth with 1% glucose medium
was used to determine the background OD. OD cut-off was
then determined as an average OD of negative control + 3
× standard deviation of negative control. The OD cut-off
value was separately calculated for each Microtiter plate.
Biofilm formation by isolates was calculated and catego-
rized according to the absorbance of the crystal violet-
stained attached cells (23, 24) (Table 2).
2.5.2. Congo Red Agar Method (CRA)
Phenotypic production of biofilm in all MRSA isolates
was assessed using culture on CRA plates as previously ex-
plained (12). Briefly, CRA plates were prepared by adding
0.8 g of Congo red (Sigma, USA) to 1 liter of brain heart
infusion agar (Merck, Germany). Next, the CRA was auto-
claved in 120°C for 15 minutes and then, 36 g of Saccharose
(Merck, USA) was added using filtering. The plates were in-
cubated for 48 hours at 37°C. The morphology of colonies
was then interpreted based on colony color as pink, brown,
and black (25, 26).
2.6. Statistical Analysis
The relationship between biofilm formation and drug
resistance among MRSA isolates was evaluated by the Pear-
son Chi-Square test using SPSS version 21. P values less than
0.05 were considered significant.
3. Results
3.1. Samples Collection
In total, 98 clinical specimens were collected from
blood (10.2%), throat (52%), wound (5.1%), sputum (5.1%), and
other sources (27.6%). Participants were 52% girls and 48%
boys. The mean age was 54 months. The youngest and
the oldest patients had 1 month and 17 years of age, respec-
tively.
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Table 1. Target Genes and Their Primers Used in the Study
Primer Sequence (5’ - 3’) Products Sizes, bp Annealing, °C Ref.
Nuc
F-GCGATTGATGGTGATACGGTT
270 54 (19)
R-AGCCAAGCCTTGACGAACTAAAGC
mecA
F-GTAGAAATGACTGAACGTCCGATAA
310 55 (20)
R-CCAATTCCACATTGTTTCGCTCTAA
Table 2. Classification of Biofilm Formation Abilities by Microtiter Plate Method
Cut-Off Value
Calculation
Mean of OD Values Biofilm Formation
Abilities
OD > 4×ODc OD > 0.2 Strong
2×ODc < OD≤ 4×
ODc
0.1 < OD≤ 0.2 Moderate
ODc < OD≤ 2×ODc 0.05 < OD≤ 0.1 Weak
OD≤ODc OD≤ 0.05 Negative
3.2. Antibiogram Profile of Isolates
All the 98 (100%) MRSA isolates were found to be resis-
tant to cefoxitin (30 µg) using disc diffusion method. Fig-
ure 1 shows the results of antibiotic resistance testing of
the MRSA isolates for the nine antibiotics studied. The pat-
tern of Minimal Inhibitory Concentration of vancomycin
on the MRSA isolates was determined with concentrations
varying from 0.19 to 2.5µg/mL.
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Figure 1. Antimicrobial Resistance Pattern of MRSA Isolates
3.3. Detection of nuc and mecA using PCR
PCR revealed the presence of nuc and mecA genes (270
and 310 bp, respectively) in all 98 isolates (100%). The PCR
products of nuc and mecA genes were sequenced and they
were documented with Accession numbers KU163299 and
KX024711, respectively, in Gen Bank, NCBI.
3.4. Detection of Biofilm Formation
3.4.1. Microtiter Plate Assay
The Mtp assay results showed that MRSA isolates were
attached at different amounts. Attachment abilities were
strong in 1 (1%) strain, moderate in 8 (8.2%) strains, and weak
in 53 (54.1%) strains, while 36 (36.7%) of them had no attach-
ment ability (Table 3).
Table 3. Biofilm Formation of MRSA Isolates in Mtp and CRA Methods
Method Biofilm formation Number Percentage
Congo red agar
method
Black 56 57.1
Brown 24 24.5
Pink 17 17.3
Microtiter plate assay
Strong 1 1
Moderate 8 8.2
Weak 53 54.1
Negative 36 36.7
3.4.2. Congo Red Method
In this method, 57.1%, 24.5%, and 17.3% of MRSA isolates,
respectively, showed black colonies (Strong biofilm pro-
ducers), brown colonies (Weak biofilm producers), and red
colonies (non-biofilm producers).
4. Discussion
The attachment and biofilm formation on surfaces
causes bacterial resistance to inappropriate conditions
such as antibiotics and immune response (27, 28). All of
the 98 MRSA isolates were examined for their potential for
biofilm formation. Using the Mtp method, 62 (63.3%) iso-
lates were found to be biofilm producers among which, 9
(9.2%) strains were highly biofilm-positive (OD630 > 0.1)
and 53 (54.1%) were low-grade biofilm producer, while 36
(36.7%) strains produced no biofilm. Other studies have
reported a slightly higher number of biofilm producers
among Staphylococcal species (23, 29).
In the CRA method, biofilm formation was observed in
80 (81.6%) isolates whereas 17 (17.3%) strains did not show
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any biofilm formation. This finding is in agreement with
that of the study by Turkyilmaz et al. who detected biofilm
production in 74.4% of isolates using CRA method (30).
Among the phenotypic methods, Mtp assay has been re-
ported as the gold standard for biofilm formation (14). CRA
method is easy to perform and interpret, but due to its low
specificity and sensitivity, we do not recommend it for de-
tection of biofilm formation (31). When S. aureus assumes
the biofilm phenotype, the associated infections are often
extremely difficult to treat (32).
In the present study, antimicrobial resistance was 100%
for penicillin and cefoxitin, 57% for erythromycin, 54%
for clindamycin, 24% for trimethoprim- sulfamethoxazole,
22% for gentamycin, 12% for rifampicin, and 6% for minocy-
cline, but all these isolates were susceptible to vancomycin
and linezolid. Therefore, vancomycin, linezolid, and other
glycopeptide drugs have remained the last resorts for
treatment of S. aureus, especially MRSA-induced infections
(33). A similar study was performed by Yousefi and his col-
leagues in 2016 in Iran. They determined the biofilm for-
mation and antibiotic resistance pattern of Staphylococcus
aureus isolated from urinary tract infection. They reported
that 69.2% of S. aureus isolates were biofilm producers
and resistance to four antibiotics, namely nitrofurantoin
(71.4%/28.6%), tetracycline (57.7%/42.3%), erythromycin, and
ciprofloxacin (56%/44) was higher among biofilm produc-
ers than among non-biofilm producers (29). These find-
ings were consistent with our findings in the present study.
CharanKaur and Khare conducted a similar study in
2013 in India on biofilm investigation and antimicrobial
susceptibility of MRSA isolates. Out of 231 isolates, 182
(78.8%) of the Methicillin resistant Staphylococcus aureus
isolates were found to form biofilm (34).
In our study, the antibiotic resistance pattern was
higher in biofilm-producing MRSA than in non-biofilm-
producers (Figure 2) although statistical analysis showed
no significant relationship between biofilm formation and
some antibiotic resistance; a finding that was previously
reported by other researchers, too (9, 35).
The increased resistance of biofilm producing strains
to antibiotics may be because the biofilm bacteria exhibit a
slow rate of metabolism and divide infrequently, resulting
in the decreased sensitivity to antibiotics targeted at cell
wall synthesis (36). However, even antibiotics that target
cellular functions, such as protein and DNA synthesis, can-
not be effective on biofilm-producing organisms as they
are at a quiescent state (37).
4.1. Conclusion
Unfortunately, the prevalence of Methicillin resistant
Staphylococcus aureus isolates is rising and biofilm forma-
tion has an important role in the development of antibi-
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Figure 2. Antimicrobial Resistance in Biofilm Producers and Non-Producers
otic resistance. Thus, early identification of these isolates
and detection of biofilm formation by Mtp method are
the essential steps towards the prevention of most serious
nosocomial infections.
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